Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...
The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body ...
Final draft guidance published by Nice shows NHS England requested that Mounjaro is rolled out over a period of 12 years. The ...
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a ...
Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made available to around 220,000 people in the country via the state health ...
The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible ...
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
Fewer than one in ten patients who meet the criteria for Mounjaro will be given it by the health service over the next three ...
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
Actor and comedian Jim Gaffigan made sure his 50-pound weight loss was funny business, discussing the topic in his November ...
The paper says France is in "turmoil" and the crisis will "reverberate across Europe", noting that former Brexit negotiator ...
Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.